Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events.

A worrying trend toward a higher and increasing incidence of kidney failure (dialysis or transplantation) over time was observed during the trial and in the early post-trial follow-up (up to 6–7 years).

also in 375 other papers